Charles R Schaller - Director, Celldex Therapeutics, Inc

As of September 13, 2010


Charles R Schaller Net Worth

  • Net worth is estimated to be at least $146.88K
  • Owns at least 5,000 units of Celldex Therapeutics, Inc stock

Charles R Schaller Trading

  • Largest purchase of shares was 10,000 units , worth over $51.56K on November 12, 2009
  • In total has made about 5 transactions over 2 years
  • Usually trades in December and November, with the busiest year in 2009
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Celldex Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

Celldex Therapeutics, Inc Insider Trading

  • The most recent transaction was 430 units bought on August 13, 2021 by Freddy A Jimenez worth over $19.9K
  • In the last 13 years, insiders at Celldex Therapeutics, Inc sold an estimated value of $21.91M and bought an estimated value of $4.24M
  • The most active traders are Gerald McMahon, Director,  Avery W Catlin, Sr. VP & CFO,  and Anthony S Marucci, President & CEO
  • Insider trading is most common in June, with the busiest year in 2018

Celldex Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1